LIT M Tablets
Composition
Each tablet contains:
Montelukast sodium IP equivalent to montelukast……………10 mg
Levocetirizine dihydrochloride IP…………………………………….5 mg
Indications
LIT M Tablets tablets is indicated for relief of symptoms of allergic rhinitis (seasonal and perennial). LIT M indicated for prevention of exercise-induced broncho-constriction in patients 6 years of age and older.
Dosage and Administration
LIT M Tablets
Adults 1 tablet once daily
Contraindications
LIT M Tablets are contraindicated in patients with known hypersensitivity to montelukast, levocetirizine, to other piperazine derivatives or to any of the excipients. Also, contradicted in patients with severe renal impairment at less than 10 ml/min creatinine clearance. Children 6 months to 11 years of age with impaired renal function should not be administered LIT M Dispersible tablets .
Packaging Information
LIT M Tablets……………Blister pack of 10 tablets